Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market
Holding ACTU?
Track your performance easily

Actuate Therapeutics, Inc. (ACTU) Financial Statements

6 Followers

Actuate Therapeutics, Inc. Financial Overview

Actuate Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Actuate Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23
Income Statement-
Total Revenue--
Gross Profit--
EBIT$ -8.29M-
EBITDA$ -8.29M-
Net Income Common Stockholders$ -8.30M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.07M$ 2.96M
Total Assets$ 2.70M$ 3.00M
Total Debt$ 0.00$ 0.00
Net Debt$ -2.07M$ -2.96M
Total Liabilities$ 16.29M$ 8.44M
Stockholders Equity$ -13.60M$ -5.45M
Cash Flow-
Free Cash Flow$ -5.25M-
Operating Cash Flow$ -5.25M-
Investing Cash Flow--
Financing Cash Flow$ 4.36M-
Currency in USD

Actuate Therapeutics, Inc. Earnings and Revenue History

Actuate Therapeutics, Inc. Debt to Assets

Actuate Therapeutics, Inc. Cash Flow

Actuate Therapeutics, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis